CareersPipelineCollaboration RareInnovation SVGOMG The best SVG optimizer and minifier Open SVG Paste markup Demo Contribute SVGOMG provides you several options to clean and compress your SVG files. Clean up, remove, merge, minify. Upload or copy the source of your SVG to get started! 947 bytes → 267 bytes 28.19% Finance peopleAdvance treatment Skip to main contentSkip to navigationSkip to search
HNSA   ( ,  %) SEK
Quotes are delayed 15 minutes

Empowering

people living with

rare immunologic diseases 

We develop innovative immunomodulating therapies with the potential to transform the lives of people affected by rare immunologic conditions.

Media

Our latest announcements

Our science

Our unique antibody-cleaving enzyme technology

Our proprietary antibody-cleaving enzymes imilfidase and HNSA-5487 target and inactivate IgG antibodies in the blood and tissues, inhibiting the IgG-mediated immune responses, helping halt the progression of IgG-driven acute autoimmune diseases, as well as enable lifesaving and life altering procedures and therapies.

Our focus area

We aim to address unmet need in conditions where the IgG-driven immune response becomes harmful, or it interferes with the delivery of lifesaving and life altering therapies.

For Investors

Calendar

Upcoming events

07
Nov

Truist Securities BioPharma Symposium, New York

19
Nov

SEB Healthcare Seminar 2024, Stockholm

19
Nov

Jefferies Global Healthcare Conference, London

View all events
Latest Financial Results

Interim report January-September 2024

View all results

Annual Report 2023
Sustainability Report 2023

Addressing unmet need in rare diseases

Read the reports

Media articles

Discover more

Partner with us

Our partnership model is focused in three key areas – drug discovery and development, commercialization and distribution / licensing. 

Partnerships

Join us

Ready for a new career? Check out our job opportunities.

A truly great place to work

For five years Hansa has been awarded the Great Place To Work designation by the independent institute Great Place To Work®, a global authority on workplace culture, employee experience and leadership behavior. 

Job opportunities

E-mail

Sign up to receive the latest updates

Choose type

I consent to Hansa Biopharma handling my personal data. See our Privacy Policy for information about how we handle personal data.

Thank you. You will get an e-mail message to activate your subscription.